Role of vasoactive intestinal peptide in inflammation and autoimmunity
- PMID: 16312132
Role of vasoactive intestinal peptide in inflammation and autoimmunity
Abstract
Vasoactive intestinal peptide (VIP), a peptide produced by immune cells, exerts a wide spectrum of immunological functions that control the homeostasis of the immune system. In the last decade, VIP has been clearly identified as a potent anti-inflammatory factor, both in innate and adaptive immunity. In innate immunity, this peptide inhibits the production of inflammatory cytokines and chemokines from macrophages, microglia and dendritic cells. In addition, VIP reduces the expression of co-stimulatory molecules on antigen-presenting cells, and therefore reduces stimulation of antigen-specific CD4 T-cells. In terms of adaptive immunity, VIP promotes T-helper (Th)2-type responses, and reduces inflammatory Th1-type responses. Several of the molecular mechanisms involved in the inhibition of cytokine and chemokine expression, and in the preferential development and/or survival of Th2 effectors are known. Therefore, VIP and its analogs have been proposed as promising alternative candidates to existing therapies for the treatment of acute and chronic inflammatory and autoimmune diseases. The aim of this review is to update knowledge of the cellular and molecular events that are relevant to VIP function in the immune system. The central functions that VIP plays in cellular processes is being recognized and attention is being focused on this important peptide with regard to exciting new candidates for therapeutic intervention and drug development.
Similar articles
-
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.J Mol Med (Berl). 2002 Jan;80(1):16-24. doi: 10.1007/s00109-001-0291-5. Epub 2001 Oct 17. J Mol Med (Berl). 2002. PMID: 11862320 Review.
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):127-42. Cell Mol Biol (Noisy-le-grand). 2003. PMID: 12887096 Review.
-
VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.J Leukoc Biol. 2004 Jun;75(6):1122-30. doi: 10.1189/jlb.1203626. Epub 2004 Mar 12. J Leukoc Biol. 2004. PMID: 15020654
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.Glia. 2002 Aug;39(2):148-61. doi: 10.1002/glia.10098. Glia. 2002. PMID: 12112366
-
Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.Gastroenterology. 2006 Dec;131(6):1799-811. doi: 10.1053/j.gastro.2006.10.023. Epub 2006 Oct 15. Gastroenterology. 2006. PMID: 17087944
Cited by
-
Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.Obesity (Silver Spring). 2010 Dec;18(12):2339-46. doi: 10.1038/oby.2010.83. Epub 2010 Apr 8. Obesity (Silver Spring). 2010. PMID: 20379146 Free PMC article.
-
VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.PLoS One. 2012;7(2):e29790. doi: 10.1371/journal.pone.0029790. Epub 2012 Feb 6. PLoS One. 2012. PMID: 22328918 Free PMC article.
-
Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs.Arthritis Res Ther. 2009;11(4):237. doi: 10.1186/ar2752. Epub 2009 Aug 4. Arthritis Res Ther. 2009. PMID: 19664198 Free PMC article. Review.
-
Dietary supplementation with pyrroloquinoline quinone promotes growth, relieves weaning stress, and regulates metabolism of piglets compared with adding zinc oxide.Anim Nutr. 2023 Oct 4;15:409-419. doi: 10.1016/j.aninu.2023.06.015. eCollection 2023 Dec. Anim Nutr. 2023. PMID: 38046955 Free PMC article.
-
Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions.BMC Genomics. 2009 Nov 2;10:507. doi: 10.1186/1471-2164-10-507. BMC Genomics. 2009. PMID: 19883504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials